Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples

BACKGROUND: Genomic tests are available to predict breast cancer recurrence and to guide clinical decision making. These predictors provide recurrence risk scores along with a measure of uncertainty, usually a confidence interval. The confidence interval conveys random error and not systematic bias....

Descripción completa

Detalles Bibliográficos
Autores principales: Elloumi, Fathi, Hu, Zhiyuan, Li, Yan, Parker, Joel S, Gulley, Margaret L, Amos, Keith D, Troester, Melissa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151208/
https://www.ncbi.nlm.nih.gov/pubmed/21718502
http://dx.doi.org/10.1186/1755-8794-4-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151208/
https://www.ncbi.nlm.nih.gov/pubmed/21718502
http://dx.doi.org/10.1186/1755-8794-4-54

Ejemplares similares